Genomic Medicine is making a rapid entry into the healthcare landscape, but questions on the potential vs realized impacts toward clinical care outcomes persist. Which genomic information will be crucial to patient care? Addressing this and other questions with host Dr. Howard Levy is Dr. Robert Green, Director of the Genes-2-People (G2P) Research Program in Translational Genomics and Health Outcomes at Brigham and Women's Hospital and Harvard Medical School.
Translational Genomics and Health Outcomes Research: What's Ready for Primetime?
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Genomic Medicine is making a rapid entry into the healthcare landscape, but questions on the potential vs realized impacts toward clinical care outcomes persist. Which genomic information will be crucial to patient care? Addressing this and other questions with host Dr. Howard Levy is Dr. Robert Green, Director of the Genes-2-People (G2P) Research Program in Translational Genomics and Health Outcomes at Brigham and Women's Hospital and Harvard Medical School.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?